🇺🇸 FDA
Patent

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

granted A61KA61K38/1709A61P

Quick answer

US patent 7541139 (Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/1709, A61P, A61P31/00, A61P37/04